BGI Genomics provides a wide range of next generation sequencing services and a broad portfolio of genetic tests for medical institutions, research institutions and other public and private partners.

BGI’s mission is to leverage its genomics expertise in order to advance life science research and improve human health for the benefit of mankind.

BGI has particular strengths in prenatal screening, hereditary cancer screening, testing for rare disease and in aiding precision medicine research and initiatives.

Numerous scientific partners, healthcare providers and pharmaceutical companies have come to rely on BGI’s world leading bio-informatics research and development, large scale computing infrastructure for data output and storage, and proprietary sequencing platforms.

BGI is headquartered in Shenzhen, China, with branches and medical laboratories in major cities including Beijing, Tianjin, Wuhan, Shanghai and Guangzhou. BGI also has offices and laboratories located in Europe, North America and the Asia Pacific region.

BGI currently operates in more than 100 countries and regions and works with more than 3000 medical institutions and more than 300 hospitals.